Stock CTNM CONTINEUM THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Contineum Therapeutics, Inc.

Equities

CTNM

US21217B1008

Market Closed - Nasdaq
Other stock markets
 01:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
19.93 USD +3.86% Intraday chart for Contineum Therapeutics, Inc. +4.62% 0.00%
24/06 Contineum Therapeutics, Inc. Appoints Sarah Boyce as Independent Member of its Board of Directors CI
24/06 Contineum Therapeutics, Inc.(NasdaqGS:CTNM) added to S&P TMI Index CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
BU
Contineum Therapeutics, Inc. Appoints Sarah Boyce as Independent Member of its Board of Directors
CI
Contineum Therapeutics, Inc.(NasdaqGS:CTNM) added to S&P TMI Index
CI
Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference
BU
Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary
BU
Contineum Therapeutics, Inc. Appoints John Healy as General Counsel & Corporate Secretary
CI
Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors
BU
Contineum Therapeutics, Inc. Appoints Troy Ignelzi as Independent Member of Its Board of Directors and as Chair of the Audit Committee
CI
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
BU
Morgan Stanley Starts Contineum Therapeutics With Overweight Rating
MT
Stifel Starts Contineum Therapeutics With Buy Rating, $29 Price Target
MT
RBC Initiates Contineum Therapeutics at Outperform, Speculative Risk With $30 Price Target
MT
Contineum Therapeutics, Inc.(NasdaqGS:CTNM) added to NASDAQ Composite Index
CI
Sector Update: Health Care Stocks Rise Late Afternoon
MT
Sector Update: Health Care
MT
Contineum Therapeutics' Shares Fall After IPO Pricing
MT
Contineum Therapeutics Prices IPO at $16 a Share
MT
Contineum Therapeutics Announces Pricing of Initial Public Offering
AQ
Contineum Therapeutics, Inc. has completed an IPO in the amount of $110 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTNM Stock
  4. News Contineum Therapeutics, Inc.